Literature DB >> 26666560

Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.

Moon Hyung Choi1, Soon Nam Oh1, Sung Eun Rha1, Joon-Il Choi1, Sung Hak Lee2, Hong Seok Jang3, Jun-Gi Kim4, Robert Grimm5, Yohan Son6.   

Abstract

PURPOSE: To investigate the usefulness of apparent diffusion coefficient (ADC) values derived from histogram analysis of the whole rectal cancer as a quantitative parameter to evaluate pathologic complete response (pCR) on preoperative magnetic resonance imaging (MRI).
MATERIALS AND METHODS: We enrolled a total of 86 consecutive patients who had undergone surgery for rectal cancer after neoadjuvant chemoradiotherapy (CRT) at our institution between July 2012 and November 2014. Two radiologists who were blinded to the final pathological results reviewed post-CRT MRI to evaluate tumor stage. Quantitative image analysis was performed using T2 -weighted and diffusion-weighted images independently by two radiologists using dedicated software that performed histogram analysis to assess the distribution of ADC in the whole tumor.
RESULTS: After surgery, 16 patients were confirmed to have achieved pCR (18.6%). All parameters from pre- and post-CRT ADC histogram showed good or excellent agreement between two readers. The minimum, 10th, 25th, 50th, and 75th percentile and mean ADC from post-CRT ADC histogram were significantly higher in the pCR group than in the non-pCR group for both readers. The 25th percentile value from ADC histogram in post-CRT MRI had the best diagnostic performance for detecting pCR, with an area under the receiver operating characteristic curve of 0.796.
CONCLUSION: Low percentile values derived from the ADC histogram analysis of rectal cancer on MRI after CRT showed a significant difference between pCR and non-pCR groups, demonstrating the utility of the ADC value as a quantitative and objective marker to evaluate complete pathologic response to preoperative CRT in rectal cancer. J. Magn. Reson. Imaging 2016;44:212-220.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  apparent diffusion coefficient (ADC); chemoradiotherapy; histogram; rectal cancer

Mesh:

Substances:

Year:  2015        PMID: 26666560     DOI: 10.1002/jmri.25117

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  27 in total

1.  Prediction of Clinical Pathologic Prognostic Factors for Rectal Adenocarcinoma: Volumetric Texture Analysis Based on Apparent Diffusion Coefficient Maps.

Authors:  Zhihua Lu; Lei Wang; Kaijian Xia; Heng Jiang; Xiaoyan Weng; Jianlong Jiang; Mei Wu
Journal:  J Med Syst       Date:  2019-11-07       Impact factor: 4.460

Review 2.  Diffusion-weighted imaging in rectal cancer: current applications and future perspectives.

Authors:  Niels W Schurink; Doenja M J Lambregts; Regina G H Beets-Tan
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

3.  Whole-tumour diffusion kurtosis MR imaging histogram analysis of rectal adenocarcinoma: Correlation with clinical pathologic prognostic factors.

Authors:  Yanfen Cui; Xiaotang Yang; Xiaosong Du; Zhizheng Zhuo; Lei Xin; Xintao Cheng
Journal:  Eur Radiol       Date:  2017-10-23       Impact factor: 5.315

4.  Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Authors:  Yanfen Cui; Xiaotang Yang; Zhongqiang Shi; Zhao Yang; Xiaosong Du; Zhikai Zhao; Xintao Cheng
Journal:  Eur Radiol       Date:  2018-08-20       Impact factor: 5.315

5.  Whole lesion histogram analysis of apparent diffusion coefficient predicts therapy response in locally advanced rectal cancer.

Authors:  Mayra Evelia Jiménez de Los Santos; Juan Armando Reyes-Pérez; Victor Domínguez Osorio; Yolanda Villaseñor-Navarro; Liliana Moreno-Astudillo; Itzel Vela-Sarmiento; Isabel Sollozo-Dupont
Journal:  World J Gastroenterol       Date:  2022-06-21       Impact factor: 5.374

Review 6.  Rectal MRI radiomics for predicting pathological complete response: Where we are.

Authors:  Joao Miranda; Gary Xia Vern Tan; Maria Clara Fernandes; Onur Yildirim; John A Sims; Jose de Arimateia Batista Araujo-Filho; Felipe Augusto de M Machado; Antonildes N Assuncao-Jr; Cesar Higa Nomura; Natally Horvat
Journal:  Clin Imaging       Date:  2021-11-16       Impact factor: 2.420

7.  Validation of the standardized index of shape tool to analyze DCE-MRI data in the assessment of neo-adjuvant therapy in locally advanced rectal cancer.

Authors:  Roberta Fusco; Vincenza Granata; Mario Sansone; Daniela Rega; Paolo Delrio; Fabiana Tatangelo; Carmen Romano; Antonio Avallone; Davide Pupo; Marzia Giordano; Roberto Grassi; Vincenzo Ravo; Biagio Pecori; Antonella Petrillo
Journal:  Radiol Med       Date:  2021-05-26       Impact factor: 3.469

8.  MR imaging perfusion and diffusion analysis to assess preoperative Short Course Radiotherapy response in locally advanced rectal cancer: Standardized Index of Shape by DCE-MRI and intravoxel incoherent motion-derived parameters by DW-MRI.

Authors:  Antonella Petrillo; Roberta Fusco; Vincenza Granata; Sergio Venanzio Setola; Mario Sansone; Daniela Rega; Paolo Delrio; Francesco Bianco; Giovanni Maria Romano; Fabiana Tatangelo; Antonio Avallone; Biagio Pecori
Journal:  Med Oncol       Date:  2017-11-18       Impact factor: 3.064

9.  The impact of the mesorectal apparent diffusion coefficient value on surgical difficulty in laparoscopic anterior resection for rectal cancer.

Authors:  Hirofumi Suzumura; Masashi Tsuruta; Hirotoshi Hasegawa; Koji Okabayashi; Takashi Ishida; Yusuke Asada; Akitsugu Makino; Shigeo Okuda; Yuko Kitagawa
Journal:  Surg Today       Date:  2018-10-19       Impact factor: 2.549

Review 10.  Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.

Authors:  Samuel G Armato; Kevin G Blyth; Jane J Keating; Sharyn Katz; Selina Tsim; Johan Coolen; Eyjolfur Gudmundsson; Isabelle Opitz; Anna K Nowak
Journal:  Lung Cancer       Date:  2016-09-05       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.